Polymorphisms of FAS and FAS ligand genes in preeclamptic women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 148, Issue 2, 2010, Pages 144-146

  Ciarmela, Pasquapina ^a   Boschi, Sonia ^b   Bloise, Enrrico ^b   Marozio, Luca ^c   Benedetto, Chiara ^c   Castellucci, Mario ^a   Petraglia, Felice ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Fas; Fas ligand; Genetic polymorphism; Preeclampsia; Pregnancy

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GENOMIC DNA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUNGARY; HYPOTHESIS; ITALY; PATHOGENESIS; POPULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION;

EID: 73749088459     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.10.026     Document Type: Article

References (30)

1. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
2. Lain K.Y., and Roberts J.M. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287 (2002) 3183-3186
3. Gyongyossy A., and Kelentey B. An experimental study of the effect of ischaemia of the pregnant uterus on the blood pressure. J Obstet Gynaecol Br Emp 65 (1958) 617-624
4. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
5. Gervasi M.T., Chaiworapongsa T., Pacora P., et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 185 (2001) 792-797
6. Knight M., Redman C.W., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 105 (1998) 632-640
7. DiFederico E., Genbacev O., and Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155 (1999) 293-301
8. Burton G.J., and Jones C.J. Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta. Taiwan J Obstet Gynecol 48 (2009) 28-37
9. Heazell A.E., and Crocker I.P. Live and let die-regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 29 (2008) 772-783
10. Frangsmyr L., Baranov V., Nagaeva O., Stendahl U., Kjellberg L., and Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 11 (2005) 35-41
11. Iannolo G., Conticello C., Memeo L., and De Maria R. Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66 (2008) 42-51
12. Call J.A., Eckhardt S.G., and Camidge D.R. Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol 9 (2008) 1002-1011
13. Lorenzo H.K., and Susin S.A. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Drug Resist Updat 10 (2007) 235-255
14. Mollinedo F., and Gajate C. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 9 (2006) 51-73
15. Trauth B.C., Klas C., Peters A.M., et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245 (1989) 301-305
16. Stoneman V.E., and Bennett M.R. Role of Fas/Fas-L in vascular cell apoptosis. J Cardiovasc Pharmacol 53 (2009) 100-108
17. Sziller I., Nguyen D., Halmos A., Hupuczi P., Papp Z., and Witkin S.S. An A > G polymorphism at position -670 in the Fas (TNFRSF6) gene in pregnant women with pre-eclampsia and intrauterine growth restriction. Mol Hum Reprod 11 (2005) 207-210
18. Wallenburg H.C. Prevention of pre-eclampsia: status and perspectives 2000. Eur J Obstet Gynecol Reprod Biol 94 (2001) 13-22
19. Ciarmela P., Florio P., Battistini S., et al. Mutational analysis of the inhibin alpha gene in preeclamptic women. J Endocrinol Invest 28 (2005) 30-33
20. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
21. Zhang Z., Shi Q., Sturgis E.M., Spitz M.R., Hong W.K., and Wei Q. Thymidylate synthase 5′- and 3′-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res 10 (2004) 7903-7910
22. Sun T., Miao X., Zhang X., Tan W., Xiong P., and Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96 (2004) 1030-1036
23. Pinti M., Troiano L., Nasi M., et al. Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ 9 (2002) 431-438
24. Fleiss J. Statistical methods for rates and proportion (1981), John Wiley and sons, NY Chapter 2
25. Csanyi B., Bogacsi-Szabo E., Tomory G., et al. Y-chromosome analysis of ancient Hungarian and two modern Hungarian-speaking populations from the Carpathian Basin. Ann Hum Genet 72 (2008) 519-534
26. Guglielmino C.R., De Silvestri A., and Beres J. Probable ancestors of Hungarian ethnic groups: an admixture analysis. Ann Hum Genet 64 (2000) 145-159
27. Tomory G., Csanyi B., Bogacsi-Szabo E., et al. Comparison of maternal lineage and biogeographic analyses of ancient and modern Hungarian populations. Am J Phys Anthropol 134 (2007) 354-368
28. Lai H.C., Sytwu H.K., Sun C.A., et al. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103 (2003) 221-225
29. Abrahams V.M., Straszewski-Chavez S.L., Guller S., and Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10 (2004) 55-63
30. Miko E., Szereday L., Barakonyi A., Jarkovich A., Varga P., and Szekeres-Bartho J. Immunoactivation in preeclampsia: Vdelta2+ and regulatory T cells during the inflammatory stage of disease. J Reprod Immunol 80 (2009) 100-108